CDSCO’s expert panel recommends approval for phase 1 trial of Bharat Biotech’s nasal vaccine for COVID-19 Read more
Centaur Pharma to start post-marketing surveillance study of diabetic drug by end of January 2021 Read more
SEC asks Bharat Serums to revise phase I/II trial protocols for equine antiserum to treat COVID-19 Read more
Zydus seeks approval for Phase III clinical trials of ZyCoV-D, submits Phase I/II clinical trial data Read more